THE COMPARATIVE EFFECTIVENESS OF CYCLING TUMOURNECROSIS FACTOR INHIBITOR (TNFI) VERSUS SWAPPING TO A NONTNFI ON PATIENT-REPORTED FUNCTIONAL ABILITY OF PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
作者：
Lopez-Oliva, M. A. [1 ]
Matusevich, A. [1 ]
Cantor, S. B. [2 ]
Pratt, G. [3 ]
Suarez-Almazor, M. E. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Gen Internal Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Hlth Serv Res, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Res Med Lib, Houston, TX 77030 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷
关键词：
D O I：
10.1136/annrheumdis-2018-eular.6989
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0298
引用
收藏
页码：196 / 196
页数：1
相关论文
共 50 条
[31]   Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis [J].
Strand, Vibeke ;
Gossec, Laure ;
Proudfoot, Clare W. J. ;
Chen, Chieh-I ;
Reaney, Matthew ;
Guillonneau, Sophie ;
Kimura, Toshio ;
van Adelsberg, Janet ;
Lin, Yong ;
Mangan, Erin K. ;
van Hoogstraten, Hubert ;
Burmester, Gerd R. .
ARTHRITIS RESEARCH & THERAPY, 2018, 20
[32]   Impact of patient-reported flares on radiographic progression and functional impairment in patients with rheumatoid arthritis: a cohort study based on the AMBRA trial [J].
Kuettel, D. ;
Primdahl, J. ;
Christensen, R. ;
Ornbjerg, L. M. ;
Horslev-Petersen, K. .
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (02) :87-94
[33]   PATIENT-REPORTED OUTCOMES WITH SARILUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS ARE SIMILAR REGARDLESS OF PRIMARY OR SECONDARY FAILURE WITH TUMOUR NECROSIS FACTOR INHIBITORS [J].
Strand, V. ;
Boklage, S. ;
Mangan, E. ;
Reaney, M. ;
Iglesias-Rodriguez, M. ;
Kimura, T. .
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 :615-616
[34]   Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis Replication reply [J].
Sugawara, Eri ;
Matsui, Kazuo ;
Amasaki, Yoshiharu .
JOURNAL OF RHEUMATOLOGY, 2022, 49 (04) :438-438
[35]   Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti-tumor necrosis factor therapy [J].
Keystone, E. ;
Burmester, G. R. ;
Furie, R. ;
Loveless, J. E. ;
Emery, P. ;
Kremer, J. ;
Tak, P. P. ;
Broder, M. S. ;
Yu, E. ;
Cravets, M. ;
Magrini, F. ;
Jost, F. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (06) :785-793
[36]   Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach [J].
Hye-Lin Kim ;
Min-Young Lee ;
Sun-Young Park ;
Sun-Kyeong Park ;
Ji-Hye Byun ;
Sunhong Kwon ;
Eui-Kyung Lee .
Archives of Pharmacal Research, 2014, 37 :662-670
[37]   Comparative effectiveness of cycling of tumor necrosis factor-α (TNF-α) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-α inhibitor using a Bayesian approach [J].
Kim, Hye-Lin ;
Lee, Min-Young ;
Park, Sun-Young ;
Park, Sun-Kyeong ;
Byun, Ji-Hye ;
Kwon, Sunhong ;
Lee, Eui-Kyung .
ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (05) :662-670
[38]   PATIENT-REPORTED OUTCOMES FROM A PHASE 3 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND AN INADEQUATE RESPONSE TO TUMOR NECROSIS FACTOR INHIBITORS [J].
Smolen, J. S. ;
Kremer, J. ;
Gaich, C. ;
DeLozier, A. M. ;
Schlichting, D. ;
Xie, L. ;
Genovese, M. C. .
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 :785-786
[39]   Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial [J].
Gladman, D. D. ;
Mease, P. J. ;
Cifaldi, M. A. ;
Perdok, R. J. ;
Sasso, E. ;
Medich, J. .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (02) :163-168
[40]   Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients [J].
Alten, Rieke ;
Burmester, Gerd R. ;
Matucci-Cerinic, Marco ;
Salmon, Jean-Hugues ;
Ostor, Andrew ;
Ng, Khai Jing ;
Gerwien, Jens ;
Zaremba-Pechmann, Liliana ;
Brnabic, Alan J. M. ;
Fautrel, Bruno .
RHEUMATOLOGY AND THERAPY, 2023, 10 (06) :1575-1595
12345